Clinical trial
Evaluation of the Efficacy of Radiofrequency Ablation in the Treatment of Renal Tumors: Prospective Observational Study
NCT02850809 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Radiofrequency Ablation in the Treatment of Renal Tumors: Prospective Observational Study
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- December 31, 2015
- Enrollment
- 310 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma